Group B streptococcus: early- and late-onset infections

Area of Science:

• Neonatal infectious diseases
• Bacterial pathogenesis
• Public health interventions

Background:

• Group B Streptococcus (GBS) emerged as a significant neonatal pathogen in developed nations around the 1960s.
• Disease incidence remained stable until the 1990s, coinciding with increased prevention strategies.
• The implementation of American consensus guidelines in the mid-1990s has been linked to a reported decline in GBS disease in the US.

Purpose of the Study:

• To review key challenges and strategies in preventing neonatal GBS infections.
• To present epidemiological data on GBS disease in a northern Italian region.
• To contextualize GBS disease within the broader landscape of neonatal infections and prevention.

Main Methods:

• Literature review of GBS prevention strategies and neonatal disease trends.
• Analysis of population-based data on GBS disease from a northern Italian region.
• Synthesis of current knowledge on GBS pathogenesis and public health implications.

Main Results:

• Prevention efforts, particularly in the US following guideline implementation, have shown success in reducing GBS disease incidence.
• The review highlights the ongoing importance of GBS as a neonatal pathogen.
• Initial population data from northern Italy are presented, offering new epidemiological insights.

Conclusions:

• Effective prevention strategies are crucial for combating neonatal Group B Streptococcus infections.
• Continued surveillance and regional data collection are essential for understanding and managing GBS disease.
• The findings underscore the impact of public health initiatives on reducing the burden of neonatal bacterial infections.